FDA — authorised 16 November 2023
- Application: BLA761134
- Marketing authorisation holder: EVIVE BIOTECHNOLOGY
- Local brand name: RYZNEUTA
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 RYZNEUTA in United States
FDA authorised RYZNEUTA on 16 November 2023
Marketing authorisation
RYZNEUTA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is RYZNEUTA approved in United States?
Yes. FDA authorised it on 16 November 2023.
Who is the marketing authorisation holder for RYZNEUTA in United States?
EVIVE BIOTECHNOLOGY holds the US marketing authorisation.